Mounier N, et al. - In this cross-sectional study involving 906 men and 765 women with long-term non-Hodgkin lymphoma (NHL), researchers examined the impact of treatment regimens and health disorders on long-term fatigue levels. There is severe fatigue in high proportions of NHL survivors according to study results. According to findings, initial treatment and rituximab treatment have no influence on long-term fatigue development. Increased levels of fatigue were linked to increased age, obesity, and health disorders.